课题基金 / 基金详情

Analysis of tumor suppressor genes for breast cancer

Analysis of tumor suppressor genes for breast cancer
乳腺癌抑癌基因分析
批准号:
10151252
负责人:
MIKI Yoshio
金额:
$15.36万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas (A)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 --

项目摘要

项目成果

MIKI Yoshio的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Mutations in the BRCA1 and BRCA2 genes are involved in approximately 60% of familial breast cancers and these results indicate the existence of the 3rd major gene responsible for hereditary breast cancers. The isolation of this gene is important for the genetic testing of hereditary breast cancer. The yeast two-hybrid system was used to isolate BRCA2-binding proteins. We showed that BRCA2 formed a complex with Rad51 and the pattern of northern blot analysis of the Rad51 genewas closely similar to that of the BRCA2 gene. It is therefore possible that alterations of the Rad51 gene may be involved in the development of hereditary breast cancers. To investigate this possibility, we screened Japanese patients with hereditary breast cancer for Rad51 mutations and found a single alteration in exon 6. This was determined to be present in the germline in two patients with bilateral breast cancer. In both patients, blood DNAs showed G-to-A transition of the second nucleotide of codon 150, which … More results in the substitution of glutamine for arginine. Since this alteration was not present in patients with breast or colon cancer examined, we assume that this missense alteration is likely to represent a disease-associated mutation. Another candidate of BRCA2-binding protein, designated BRAP1, is highly homologous to Amphiphysin and BIN1, that were reported to be associated with breast carcinogenesis. The exon-intron boundaries of this gene were determined, and screening for germline mutation in breast cancer families and for somatic mutation in primary breast cancers was performed. Although no mutation was found in families and primary cancers, the expression level of the BRAP1 gene was detected to be remarkably decreased in breast cancer cell lines and pancreas cancer cell lines.We have described the possibility that a small portion of bilateral breast cancers is due to germline alterations of Rad51. However, the 3rd major breast cancer susceptibility gene remains unknown ; intense efforts will be required to isolate the gene (s) responsible. Less
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
Kato,M., et al.: "Identification of Rad51 alteration in patients with bilateral breast cancer."J Hum. Genet.. (in press).
Kato,M., et al.:“双侧乳腺癌患者 Rad51 改变的鉴定。”J Hum。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Katagiri, T., Saito, H., Shinohara, A., Ogawa, H., Kamada, N., Nakamura, Y., Miki, Y.: "Multiple possible sites of BRCA2 interacting with DNA repair protein Rad51" Genes, Chromosomes & Cancer. 21. 217-222 (1998)
Katagiri, T.、Saito, H.、Shinohara, A.、Okawa, H.、Kamada, N.、Nakamura, Y.、Miki, Y.:“BRCA2 与 DNA 修复蛋白 Rad51 相互作用的多个可能位点”基因,
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Katagiri,T.: "High proportion of missense mutations of the BRCA1 and BRCA2 gene in Japanese breast cancer families." J.Human Genet.43. 42-48 (1998)
Katagiri,T.:“日本乳腺癌家族中 BRCA1 和 BRCA2 基因错义突变的比例很高。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
18
    Study on new treatment of breast cancer targeting BRCA gene function
    • 批准号:
      16H04693
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.82万
    • 财政年份:
      2016
    • 负责人:
      MIKI Yoshio
    • 依托单位:
    Role of BRCA2 in the process of estrogen-dependent cell proliferation
    • 批准号:
      15K14394
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2015
    • 负责人:
      MIKI Yoshio
    • 依托单位:
    Elucidation of the new mechanism for breast carcinogenesis associated with early endosome.
    • 批准号:
      25640061
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2013
    • 负责人:
      MIKI Yoshio
    • 依托单位:
    Functional analysis of BRCA genes and searching for molecular partner for synthetic lethality.
    • 批准号:
      24300328
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.4万
    • 财政年份:
      2012
    • 负责人:
      MIKI Yoshio
    • 依托单位:
    国内基金
    海外基金
    PPAR抑制剂治疗BRCA1基因缺陷合并H.pylori 感染胃癌的机制研究
    • 批准号:
      2026JJ80963
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      谢勇
    • 依托单位:
    FANCD2通过与BRCA1相互作用调节自噬依赖性铁死亡影响喉鳞状细胞癌干性的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      宋俊芳
    • 依托单位:
    土家药白三七总皂苷(PNS)下调EGFR抑制 BRCA1/2 野生型卵巢癌细胞增殖的作用及机制研究
    • 批准号:
      2025JJ60644
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      肖迪
    • 依托单位:
    恶性肿瘤精准诊治新技术和新策略研究-基于乳腺癌影像病理组学的BRCA1/2基因突变多模态筛查诊断模型的研发及应用
    • 批准号:
      2025C02066
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      曹文明
    • 依托单位: